Search clinical trials for: Fluorouracil folinic acid

Total 25598 results

Jonsson Comprehensive Cancer Center
Natera, Inc.; The Joseph Drown Foundation

Recruiting

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

Stage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8 | Locally...

United States
Inhibrx, Inc.

Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Sarcoma | Pancreatic Adenocarcinoma | Ewing Sarcoma | Gastric Adenocarcinoma | Chondrosarcoma | Solid Tumors | Malignant Pleural Mesothelioma | Colorectal Adenocarcinoma | GIST | SDH-deficient Solid Tumors

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Recruiting

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage 0 Pancreatic Cancer AJCC v8 | Stage I Pancreatic Cancer AJCC v8

United States
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Lynch Syndrome | Stage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | DNA Repair Disorder

United States, Puerto Rico, Germany
Assistance Publique - Hôpitaux de Paris

Completed

Impact of Folates in the Care of the Male Infertility (FOLFIV)

Male Infertility

France
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. (COLAGE)

Quality of Life | Metastatic Colorectal Cancer | Elderly Patients

France
Yale University

Terminated

Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma

Pancreatic Cancer

United States
University of California, San Francisco
Genentech, Inc.

Terminated

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Esophageal Cancer

United States
National Cancer Institute (NCI)

Completed

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

Gastric Cancer

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI); Cancer and Leukemia Group B; NSABP Foundation... and other collaborators

Terminated

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

Colorectal Cancer

United States
Vanderbilt University
National Cancer Institute (NCI); Washington University School of Medicine; University... and other collaborators

Completed

Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

Stomach Neoplasms | Esophageal Neoplasms

United States
Bayer

Completed

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Colorectal Neoplasms

Belgium, Spain, Australia, Germany, United Kingdom, Italy, United States
NorthShore University HealthSystem
University of Chicago

Completed

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb

Completed

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer

Colorectal Cancer

United States
Ziekenhuis Oost-Limburg

Completed

Thrombin Generation and Platelet Activation in CRS/HIPEC

Pseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma; Peritoneum
University of Nebraska
National Cancer Institute (NCI)

Terminated

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Esophageal Adenocarcinoma | Adenocarcinoma of the Gastroesophageal Junction | Stage IIB Esophageal Cancer | Stage IIA Esophageal Cancer

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Terminated

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer

United States
Emory University
University of Pittsburgh; Hematology/Oncology Pharmacy Association

Recruiting

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Malignant Digestive System Neoplasm

United States
Universidade Federal de Goias
Federal University of São Paulo; Ministry of Health, Brazil; Goiania Municipal...

Completed

Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil

Anemia

Brazil
Centre Oscar Lambret

Completed

Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer (COLOCROSS)

Colorectal Cancer

France
UNICANCER

Completed

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

Colorectal Cancer

France
Centro Universitario de Tonalá

Not yet recruiting

Effect of Folic Acid on the Presentation of Nuclear Abnormalities in People With a History Drug Abuse

Drug Abuse | Genotoxicity

Mexico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Gastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Pathologic Stage IB Gastric Cancer AJCC v8 | Pathologic Stage II Gastric Cancer AJCC v8 | Pathologic... and other conditions

United States
Memorial Sloan Kettering Cancer Center
Amgen

Completed

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Breast Cancer

United States
Amgen

Completed

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Breast Cancer
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

Pancreatic Adenocarcinoma Resectable | Neoadjuvant Chemotherapy

China
University Hospital, Essen
GWT-TUD GmbH

Active, not recruiting

Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG (IMAGINE)

Gastric Cancer | Adenocarcinoma of the Esophagogastric Junction

Germany
UNICANCER

Completed

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Colorectal Cancer

France
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Colorectal Cancer

United States
Sun Yat-sen University

Active, not recruiting

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Colorectal Cancer | Liver Metastases

China
University of California, San Francisco
Sanofi; Genentech, Inc.

Terminated

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Lung Cancer | Neuroendocrine Tumor | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Colon Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Withdrawn

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Rectal Adenocarcinoma

United States
Washington University School of Medicine

Completed

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum (NORMAL-R)

Rectal Cancer | Cancer of Rectum | Cancer of the Rectum | Neoplasm, Rectum | Rectum Cancer | Rectum Neoplasms | Adenocarcinoma of the Rectum

United States
Università degli Studi dell'Insubria
Universita di Verona

Not yet recruiting

Effects of Oral Inositol Supplementation on Obstetrics Outcomes in PCOS Women (IPOSI-1)

Polycystic Ovary Syndrome
Zhao gengli
Vifor Pharma

Completed

Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health

Iron Deficiency Anemia | Iron Deficiency

China
Wageningen Centre for Food Sciences
Wageningen University

Completed

Bioavailability of Folate From a Mixed Diet Using a Stable Isotope Method

Healthy | Folate Bioavailability

Netherlands
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Colorectal Cancer | Rectal Cancer | Cancer of the Rectum

United States
SCRI Development Innovations, LLC
Sanofi

Completed

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

Rectal Cancer

United States
Yuhong Li

Completed

Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
National Cancer Institute, Naples

Completed

Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer (BRANCH)

Rectal Cancer
Washington University School of Medicine
Gateway for Cancer Research

Withdrawn

Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

Esophagogastric Cancer
University of Michigan Rogel Cancer Center

Withdrawn

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

Cancer of Head and Neck

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

Neuroendocrine Carcinoma of the Skin

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaborators

Completed

S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed

Colorectal Cancer

United States, Canada, South Africa, Puerto Rico
Sun Yat-sen University

Terminated

Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

Colorectal Cancer | Liver Metastases | HAI

China
Anne Noonan

Active, not recruiting

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Bile Duct Cancer | Gall Bladder Cancer | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage II Colon Cancer | Stage... and other conditions

United States
Barbara Ann Karmanos Cancer Institute

Completed

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

Colorectal Cancer | Pancreatic Cancer | Colon Carcinoma | Cancer of Pancreas | Pancreatic Neoplasm | Malignant Neoplasm of Large Intestine | Cancer of Colon | Malignant Tumor of Colon

United States
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Folic Acid for Prevention of Contrast Induced Nephropathy (FAPCIN)

Kidney Diseases | Urologic Diseases

China

Search clinical trials for: Fluorouracil folinic acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations